Drug Shortages Roiling Oncology Practices, Impinging on Patient Care

ASCO is encouraging members to report shortages to the FDA and the ASHP. Dr. Link said in the ASCO interview that he realized that reporting "does nothing to alleviate that burden for the patient who needs the drug today – but the FDA can act more effectively when it’s armed with current information."

Dr. Neuss, for his part, thinks that the free market is not the answer. He thinks there should be a government-run exchange of some type to manage the supply, so that patients aren’t faced with potentially-life-threatening shortages.

Dr. Neuss, Dr. Kovach, and Mr. D’Amato reported no conflicts.